| Mr Clifford K Tsai, MD | |
|
335 Se 8th Ave, Hillsboro, OR 97123-4246 | |
| (503) 681-1111 | |
| Not Available |
| Full Name | Mr Clifford K Tsai |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 335 Se 8th Ave, Hillsboro, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891761847 | NPI | - | NPPES |
| 050063000 | Other | OR | REGENCE BCBSO |
| 055439 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD16680 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tuality Community Hospital | Hillsboro, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tuality Medical Group Llc | 7416173414 | 245 |
News Archive
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Cellzome Inc. and GlaxoSmithKline have announced the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.
› Verified 5 days ago
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Cellzome Inc. and GlaxoSmithKline have announced the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.
› Verified 5 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Cellzome Inc. and GlaxoSmithKline have announced the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Clifford K Tsai, MD Po Box 4008, Portland, OR 97208-4008 Ph: (503) 372-2740 | Mr Clifford K Tsai, MD 335 Se 8th Ave, Hillsboro, OR 97123-4246 Ph: (503) 681-1111 |
News Archive
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Cellzome Inc. and GlaxoSmithKline have announced the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.
› Verified 5 days ago
Dr. Ronda L Pulse Ii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1270 Fax: 503-681-1888 | |
Steven W Eyler, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 335 Se 8th Ave, Hillsboro, OR 97221 Phone: 503-681-1111 | |
Dr. Virginia L. Hawley, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 24769 Nw West Union Rd, Hillsboro, OR 97124 Phone: 503-647-5510 Fax: 503-647-9364 | |
Agnieszka Helak, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1111 | |
Mr. Nathan J Hildebrant, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1111 | |
Bich-hang K Nguyen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1111 | |
Dr. Eleana M Price, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1111 |